Miniprotein Design: Past, Present, and Prospects

Abstract

The design and study of miniproteins, that is, polypeptide chains <40 amino acids in length that adopt defined and stable 3D structures, is resurgent. Miniproteins offer possibilities for reducing the complexity of larger proteins and so present new routes to studying sequence-to-structure and sequence-to-stability relationships in proteins generally. They also provide modules for protein design by pieces and, with this, prospects for building more-complex or even entirely new protein structures. In addition, miniproteins are useful scaffolds for templating functional domains, for example, those involved in protein-protein interactions, catalysis, and biomolecular binding, leading to potential applications in biotechnology and medicine. Here we select examples from almost four decades of miniprotein design, development, and dissection. Simply because of the word limit for this Account, we focus on miniproteins that are cooperatively folded monomers in solution and not stabilized by cross-linking or metal binding. In these cases, the optimization of noncovalent interactions is even more critical for the maintenance of the folded states than in larger proteins. Our chronology and catalogue highlights themes in miniproteins, which we explore further and begin to put on a firmer footing through an analysis of the miniprotein structures that have been deposited in the Protein Data Bank (PDB) thus far. Specifically, and compared with larger proteins, miniproteins generally have a lower proportion of residues in regular secondary structure elements (α helices, β strands, and polyproline-II helices) and, concomitantly, more residues in well-structured loops. This allows distortions of the backbone enabling mini-hydrophobic cores to be made. This also contrasts with larger proteins, which can achieve hydrophobic cores through tertiary contacts between distant regions of sequence. On average, miniproteins have a higher proportion of aromatic residues than larger proteins, and specifically electron-rich Trp and Tyr, which are often found in combination with Pro and Arg to render networks of CH-π or cation-π interactions. Miniproteins also have a higher proportion of the long-chain charged amino acids (Arg, Glu, and Lys), which presumably reflects salt-bridge formation and their greater surface area-to-volume ratio. Together, these amino-acid preferences appear to support greater densities of noncovalent interactions in miniproteins compared with larger proteins. We anticipate that with recent developments such as parametric protein design, it will become increasingly routine to use computation to generate and evaluate models for miniproteins in silico ahead of experimental studies. This could include accessing new structures comprising secondary structure elements linked in previously unseen configurations. The improved understanding of the noncovalent interactions that stabilize the folded states of such miniproteins that we are witnessing through both in-depth bioinformatics analyses and experimental testing will feed the...

Mimochrome, a metalloporphyrin‐based catalytic Swiss knife†

“…Other groups, including ours, tried to practice with the "protein ligand," in an effort to test our understanding of the fundamental mechanisms that drive heme cofactor modulation [33]. This was and still is performed either by engineering natural scaffolds or by constructing entirely new-to-nature proteins [93][94][95][96][97][98][99][100][101][102][103][104][105]. These approaches demonstrated to be powerful not only to reproduce and/or optimize the biological functions of heme-proteins but also to construct artificial metalloenzymes that catalyze reaction with unknown natural counterparts [106,107].…”

Origami Biosystems: 3D Assembly Methods for Biomedical Applications

“…For example, the manipulation of local rigidity and stacking in synthesized molecular chains composed of heterocycles with extended hydrazone and pyrimidine sequences has allowed programming of molecules that fold into helical shapes . Peptidomimetic foldamers consist of modified amino acids that stabilize secondary structures and fix specific portions of the molecule while mini‐proteins are short polypeptide chains, typically <40 amino acids in length that can fold into 3D structures . In order to design secondary structures, β‐peptide homopolymers can be utilized to create sheets while α‐peptides can be utilized to create sinusoidal or helical shapes.…”

“…Reminiscent of the ancient art of origami, these methods utilize either manual or self‐folding to create integrated structures with 3D form and function. There are many review articles on molecular and thin‐film assembly approaches based on folding; the reader is directed to several recent reviews on molecular folding and to reviews on static and reconfigurable curving and folding of thin films . Here, we focus on unifying assembly methods based on manipulation of shape by bending, curving, and folding and on uncovering underlying principles across length scales from molecules to the macroscale, with a focus on integrated systems of relevance to biology and medicine.…”

Ribosomal Peptides and Small Proteins on the Rise

“…One indicator of the growth and activity in this research field is the heterogeneous nomenclature for these ORFs and their products within a given cell: they are variously named short/small ORFs (sORF/smORFs), micro ORFs (miORFs), upstream ORFs (uORFs), short‐/small‐ORF‐encoded peptides (SEPs, sPEPs), short proteins, small peptides, microproteins (miPs), miniproteins, small proteins, small cellular proteome and micro proteome (Scheme ) . Adding to the confusion, one also has to take into account the arbitrarily set boundary used to distinguish between peptides and proteins at a size of 50 aa residues, despite the fact that commonly a cut‐off of 100 amino acid residues is applied .…”